The osteoporosis and its relation with alveolar bone loss in inflammatory bowel disease patients

Abstract

The aim of this review was to evaluate the plausibility of a possible relation between osteoporosis and clinical attachment lossin patients with inflammatory bowel disease (IBD). The IBD is a chronic inflammatory condition, resultant of a modified replyof the host, and one of its extra-intestinal manifestations is the osteoporosis, which is a systemic disease that presents a loss ofbone mass density, deterioration of the skeletal structure, resulting in a fragility fracture. The periodontal disease results froman abnormal immune response and it characterizes for loss of bone structure. Patients with IBD present greater clinicalattachment loss, which includes alveolar bone loss, than otherwise healthy individuals. In the treatment of IBD, mainly in itsactivity phase of inflammation, corticosteroids are used as a therapy, which is a medicine that accelerates the process of boneloss, contributing for osteoporosis.Thereafter, we can conclude that it is plausible to believe that clinical attachment loss can be related with osteoporosis in IBDpatients, and the treatment with corticosteroids might contribute with the bone deterioration.